Concepedia

D. Krasnojon

DK

Statistics

Publications

3

Citations

494

H-Index

3

Active since

2007

Affiliations

Leningrad Regional Cancer Center(Current)

Northwestern University

D. Krasnojon is an author at Leningrad Regional Cancer Center specializing in breast cancer pharmacotherapy, metastatic breast cancer treatment, and oncology.

Publications per year

2007–2012

3

Publications

3

Significantly Longer Progression-Free Survival With <i>nab</i>-Paclitaxel Compared With Docetaxel As First-Line Therapy for Metastatic Breast Cancer

William J. Gradishar, D. Krasnojon, Sergey Cheporov et al. · Journal of Clinical Oncology · 2009 · 343 citations · Full text

, , +13

Phase II Trial of Nab-Paclitaxel Compared With Docetaxel as First-Line Chemotherapy in Patients With Metastatic Breast Cancer: Final Analysis of Overall Survival

William J. Gradishar, D. Krasnojon, Sergey Cheporov et al. · Clinical Breast Cancer · 2012 · 122 citations

, , +11

Randomized comparison of weekly or every-3-week (q3w) nab-paclitaxel compared to q3w docetaxel as first-line therapy in patients (pts) with metastatic breast cancer (MBC)

WJ Gradishar, D. Krasnojon, Sergey Cheporov et al. · Journal of Clinical Oncology · 2007 · 29 citations

, , +13

1–3 of 3